Literature DB >> 10484324

Intracellular Cl regulates Na-K-Cl cotransport activity in human trabecular meshwork cells.

L K Putney1, C R Vibat, M E O'Donnell.   

Abstract

The trabecular meshwork (TM) of the eye plays a central role in modulating intraocular pressure by regulating aqueous humor outflow, although the mechanisms are largely unknown. We and others have shown previously that aqueous humor outflow facility is modulated by conditions that alter TM cell volume. We have also shown that the Na-K-Cl cotransport system is a primary regulator of TM cell volume and that its activity appears to be coordinated with net efflux pathways to maintain steady-state volume. However, the cellular mechanisms that regulate cotransport activity and cell volume in TM cells have yet to be elucidated. The present study was conducted to investigate the hypothesis that intracellular Cl concentration ([Cl]i) acts to regulate TM cell Na-K-Cl cotransport activity, as has been shown previously for some other cell types. We demonstrate here that the human TM cell Na-K-Cl cotransporter is highly sensitive to changes in [Cl]i. Our findings reveal a marked stimulation of Na-K-Cl cotransport activity, assessed as ouabain-insensitive, bumetanide-sensitive K influx, in TM cells following preincubation of cells with Cl-free medium as a means of reducing [Cl]i. In contrast, preincubation of cells with media containing elevated K concentrations as a means of increasing [Cl]i results in inhibition of Na-K-Cl cotransport activity. The effects of reducing [Cl]i, as well as elevating [Cl]i, on Na-K-Cl cotransport activity are concentration dependent. Furthermore, the stimulatory effect of reduced [Cl]i is additive with cell-shrinkage-induced stimulation of the cotransporter. Our studies also show that TM cell Na-K-Cl cotransport activity is altered by a variety of Cl channel modulators, presumably through changes in [Cl]i. These findings support the hypothesis that regulation of Na-K-Cl cotransport activity, and thus cell volume, by [Cl]i may participate in modulating outflow facility across the TM.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10484324     DOI: 10.1152/ajpcell.1999.277.3.C373

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  6 in total

1.  Bicarbonate-dependent chloride secretion in Calu-3 epithelia in response to 7,8-benzoquinoline.

Authors:  A W Cuthbert; C T Supuran; L J MacVinish
Journal:  J Physiol       Date:  2003-07-18       Impact factor: 5.182

2.  Gramicidin-perforated patch recording revealed the oscillatory nature of secretory Cl- movements in salivary acinar cells.

Authors:  Makoto Sugita; Chikara Hirono; Yoshiki Shiba
Journal:  J Gen Physiol       Date:  2004-07       Impact factor: 4.086

3.  Agonistic β2-Adrenergic Receptor Autoantibodies Characterize the Aqueous Humor of Patients With Primary and Secondary Open-Angle Glaucoma.

Authors:  Bettina Hohberger; Max Wörn; Robert Lämmer; Aparna Mahajan; Christian Mardin; Ursula Schötzer-Schrehardt; Rudolph Kunze; Martin Herrmann; Gerd Wallukat
Journal:  Front Immunol       Date:  2021-05-05       Impact factor: 7.561

4.  Agonistic autoantibodies against ß2-adrenergic receptor influence retinal microcirculation in glaucoma suspects and patients.

Authors:  Bettina Hohberger; Sami Hosari; Gerd Wallukat; Rudolf Kunze; Johann Krebs; Meike Müller; Till Hennig; Robert Lämmer; Folkert Horn; Luis E Muñoz; Martin Herrmann; Christian Mardin
Journal:  PLoS One       Date:  2021-05-07       Impact factor: 3.240

5.  Autoantibodies Activating the β2-Adrenergic Receptor Characterize Patients With Primary and Secondary Glaucoma.

Authors:  Bettina Hohberger; Rudolf Kunze; Gerd Wallukat; Katja Kara; Christian Y Mardin; Robert Lämmer; Ursula Schlötzer-Schrehardt; Sami Hosari; Folkert Horn; Luis Munoz; Martin Herrmann
Journal:  Front Immunol       Date:  2019-10-01       Impact factor: 7.561

6.  Agonistic Autoantibodies to the β2-Adrenergic Receptor Involved in the Pathogenesis of Open-Angle Glaucoma.

Authors:  Anselm Jünemann; Bettina Hohberger; Jürgen Rech; Ahmed Sheriff; Qin Fu; Ursula Schlötzer-Schrehardt; Reinhard Edmund Voll; Sabine Bartel; Hubert Kalbacher; Johan Hoebeke; Robert Rejdak; Folkert Horn; Gerd Wallukat; Rudolf Kunze; Martin Herrmann
Journal:  Front Immunol       Date:  2018-02-12       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.